Vicky Speed
Clinical informatician
Vicky is a qualified pharmacist working at the Bennett Institute as a clinical informatician. Following a Master of Pharmacy degree from the University of Manchester she has worked as a clinical pharmacist in a number of NHS hospital trusts, and since 2014, has specialised in anticoagulation. She completed her PhD an the Institute of Pharmaceutical Science at King’s College London, which involved population pharmacokinetic modelling and a national multicentre registry to investigate the efficacy and safety of rivaroxaban in daily practice. She currently works as an anticoagulation pharmacist at King’s College Hospital, London alongside the Bennett Institute role.
Papers by Vicky Speed
- Impact of COVID-19 on recorded blood pressure screening and hypertension management in England
- Changes in opioid prescribing during the COVID-19 pandemic in England
- Incidence and treatment of group A streptococcal infections during covid-19 pandemic and 2022 outbreak
- The impact of the COVID-19 pandemic on Antidepressant Prescribing with a focus on people with learning disability and autism
- The impact of COVID-19 on azathioprine, leflunomide and methotrexate monitoring, and factors associated with change in monitoring rate
- The impact of COVID-19 on medication reviews in English primary care
- Safety of direct-acting oral anticoagulant (DOAC) prescribing
- Eleven key measures for monitoring general practice clinical activity during COVID-19
- Potentially inappropriate prescribing of DOACs to people with mechanical heart valves
Blog posts by Vicky Speed
- Exciting new developments with hospital medicines data
- The impact of COVID-19 on medication reviews in English primary care. An OpenSAFELY analysis. Part 2: Results
- The impact of COVID-19 on medication reviews in English primary care. An OpenSAFELY analysis. Part 1: Analysis Design
- Spot the difference. Part 2: Analytic Choices
- Spot the difference. Part 1: Source Datasets
- What makes a good OpenPrescribing measure?